Literature DB >> 10995019

AML1-MTG16 fusion gene in therapy-related acute leukemia with t(16;21)(q24;q22): two new cases.

F Salomon-Nguyen, M Busson-Le Coniat, M Lafage Pochitaloff, J Mozziconacci, R Berger, O A Bernard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10995019     DOI： 10.1038/sj.leu.2401885

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion.

Authors:  Linping Chen-Wichmann; Marina Shvartsman; Caro Preiss; Colin Hockings; Roland Windisch; Enric Redondo Monte; Georg Leubolt; Karsten Spiekermann; Jörn Lausen; Christian Brendel; Manuel Grez; Philipp A Greif; Christian Wichmann
Journal:  Oncogene       Date:  2018-08-09       Impact factor: 9.867

2.  Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.

Authors:  Nickolas Steinauer; Chun Guo; Chunfa Huang; Madeline Wong; Yifan Tu; Carl E Freter; Jinsong Zhang
Journal:  Blood Adv       Date:  2019-05-14

3.  Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.

Authors:  Sanne Noort; Martin Zimmermann; Dirk Reinhardt; Wendy Cuccuini; Martina Pigazzi; Jenny Smith; Rhonda E Ries; Todd A Alonzo; Betsy Hirsch; Daisuke Tomizawa; Franco Locatelli; Tanja A Gruber; Susana Raimondi; Edwin Sonneveld; Daniel K Cheuk; Michael Dworzak; Jan Stary; Jonas Abrahamsson; Nira Arad-Cohen; Malgorzata Czogala; Barbara De Moerloose; Henrik Hasle; Soheil Meshinchi; Marry van den Heuvel-Eibrink; C Michel Zwaan
Journal:  Blood       Date:  2018-08-27       Impact factor: 22.113

4.  Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia.

Authors:  Antonio Roberto Lucena-Araujo; Lorena Lobo de Figueiredo-Pontes; Fábio Morato de Oliveira; Maria de Lourdes Chauffaille; Roberto Passetto Falcao; Eduardo Magalhães Rego
Journal:  Med Oncol       Date:  2011-03-06       Impact factor: 3.064

5.  ANTI-MTG16 ANTIBODIES REVEAL MTG16 SUBCELLULAR DISTRIBUTION AND NUCLEOCYTOPLASMIC TRANSPORT IN ERYTHROLEUKEMIA CELLS.

Authors:  Hong Nguyen; Jolene Mariotti; Diana Bareyan; Robert Carnahan; Tracy Cooper; Christopher Williams; Michael Engel
Journal:  Antib Technol J       Date:  2015-02-19

6.  [Therapy-related acute myeloid leukemia with t(9;22)(q34;q11) and t(16;21)(q24;q22) double translocation: a case report and literature review].

Authors:  X Y Dong; Y L Li; C Y Wu; W Cheng; B J Shang; L Zhang; L N Cheng; Z M Zhu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-11-14

7.  Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways.

Authors:  Chien-Hung Gow; Chun Guo; David Wang; Qiande Hu; Jinsong Zhang
Journal:  Nucleic Acids Res       Date:  2013-09-24       Impact factor: 16.971
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.